외상성 뇌손상(TBI) 평가 시장, 기회, 성장 촉진요인, 산업 동향 분석과 예측(2024-2032년)

The Global Traumatic Brain Injury (TBI) Assessment Market was valued at USD 2.9 billion in 2023, with a projected CAGR of 7.4% from 2024 to 2032. Key factors driving this growth include advancements in diagnostic technologies, rising TBI incidences, an aging population, an increase in sports-related head injuries, and expanding healthcare expenditures.

TBIs, which result from accidents, falls, sports injuries, or violence, are a leading cause of morbidity and mortality worldwide. Effective assessment tools are crucial for the timely diagnosis and management of TBIs. Recent technological advancements in neuroimaging (MRI, CT scans), biomarker identification, and portable diagnostic devices have significantly improved the speed, accuracy, and convenience of TBI assessments. These innovations enhance healthcare professionals' ability to diagnose and manage TBIs more efficiently, leading to improved patient outcomes and contributing to market growth.

TBI assessment involves evaluating brain injuries caused by external forces, typically through clinical evaluations, neuroimaging, and biomarker analysis, to assess injury severity and guide treatment.

The market is divided into two main product categories: screening devices and monitoring devices. Screening devices, which include CT and MRI scans, generated USD 2.3 billion in 2023, leading the market. Monitoring devices focus on intracranial pressure (ICP) and the partial pressure of oxygen in brain tissue (pBrO2).

The increasing awareness of sports-related concussions and their long-term effects has driven the adoption of screening devices, particularly within sports organizations, educational institutions, and professional teams. Technological advancements have also led to the development of portable neuroimaging tools and handheld devices, which enhance the detection and assessment of TBIs, further driving the market for screening devices.

Hospitals, as the primary point of care for TBI cases, emerged as the dominant end use segment in 2023, with projections suggesting a market value of USD 3.2 billion by 2032. Hospitals rely heavily on advanced diagnostic tools to deliver swift and accurate TBI diagnoses, supporting specialized care and improving patient outcomes.

In 2023, North America led the TBI assessment market with USD 1.2 billion in revenue. The region's robust healthcare infrastructure, advanced medical technologies, and continuous innovations in neuroimaging and portable diagnostic tools contribute to its dominant position. North America's focus on advanced diagnostic methods and medical device innovations ensures continued growth, with a projected CAGR of 6.8% through 2032.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing incidence of traumatic brain injuries
    • 3.2.1.2 Technological advancements in traumatic brain injuries assessment
    • 3.2.1.3 Increasing demand for non-invasive devices for TBI assessment
    • 3.2.1.4 Rising awareness regarding traumatic brain injury
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Dearth of skilled professionals
    • 3.2.2.2 High cost of assessment devices
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Pricing analysis, 2023
• 3.7 Value chain analysis
• 3.8 Gap analysis
• 3.9 Key market trends
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Screening devices
  • 5.2.1 Computerized tomography (CT) scan
  • 5.2.2 Magnetic resonance imaging (MRI)
  • 5.2.3 Other screening devices
• 5.3 Monitoring devices
  • 5.3.1 Intracranial pressure (ICP) monitoring
  • 5.3.2 Partial pressure of oxygen in brain tissue (pBrO2)

Chapter 6 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Diagnostic centers
• 6.4 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
  • 7.3.7 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
  • 7.4.6 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
  • 7.5.4 Rest of Latin America
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE
  • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

• 8.1 Accuray Incorporated
• 8.2 Asahi Kasei Corporation
• 8.3 BrainScope, Inc.
• 8.4 Compumedics Ltd.
• 8.5 CurveBeam AI, Ltd.
• 8.6 FUJIFILM Holdings Corporation
• 8.7 GE Healthcare
• 8.8 InfraScan, Inc.
• 8.9 Koninklijke Philips N.V.
• 8.10 Natus Medical, Inc.
• 8.11 Neusoft Corporation
• 8.12 Nihon Kohden Corporation
• 8.13 Oculogica
• 8.14 Raumedic AG
• 8.15 Siemens Healthineers AG